These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 15492119)
21. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction. Chanrion B; Mannoury la Cour C; Gavarini S; Seimandi M; Vincent L; Pujol JF; Bockaert J; Marin P; Millan MJ Mol Pharmacol; 2008 Mar; 73(3):748-57. PubMed ID: 18083778 [TBL] [Abstract][Full Text] [Related]
22. Immunolocalization and expression of kinin B1R and B2R receptors in human inflammatory bowel disease. Stadnicki A; Pastucha E; Nowaczyk G; Mazurek U; Plewka D; Machnik G; Wilczok T; Colman RW Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G361-6. PubMed ID: 15805101 [TBL] [Abstract][Full Text] [Related]
23. Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration. Bertram CM; Baltic S; Misso NL; Bhoola KD; Foster PS; Thompson PJ; Fogel-Petrovic M J Leukoc Biol; 2007 Jun; 81(6):1445-54. PubMed ID: 17327486 [TBL] [Abstract][Full Text] [Related]
24. Molecular determinants in the second intracellular loop of the 5-hydroxytryptamine-1A receptor for G-protein coupling. Kushwaha N; Harwood SC; Wilson AM; Berger M; Tecott LH; Roth BL; Albert PR Mol Pharmacol; 2006 May; 69(5):1518-26. PubMed ID: 16410407 [TBL] [Abstract][Full Text] [Related]
25. Identification of the N-linked glycosylation sites of the human relaxin receptor and effect of glycosylation on receptor function. Yan Y; Scott DJ; Wilkinson TN; Ji J; Tregear GW; Bathgate RA Biochemistry; 2008 Jul; 47(26):6953-68. PubMed ID: 18533687 [TBL] [Abstract][Full Text] [Related]
26. Homo- and hetero-dimeric complex formations of the human oxytocin receptor. Devost D; Zingg HH J Neuroendocrinol; 2004 Apr; 16(4):372-7. PubMed ID: 15089977 [TBL] [Abstract][Full Text] [Related]
27. The signalling profile of recombinant human orexin-2 receptor. Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270 [TBL] [Abstract][Full Text] [Related]
28. Loss of association between activated Galpha q and Gbetagamma disrupts receptor-dependent and receptor-independent signaling. Evanko DS; Thiyagarajan MM; Takida S; Wedegaertner PB Cell Signal; 2005 Oct; 17(10):1218-28. PubMed ID: 16038796 [TBL] [Abstract][Full Text] [Related]
29. Stimulatory catfish leukocyte immune-type receptors (IpLITRs) demonstrate a unique ability to associate with adaptor signaling proteins and participate in the formation of homo- and heterodimers. Mewes J; Verheijen K; Montgomery BC; Stafford JL Mol Immunol; 2009 Dec; 47(2-3):318-31. PubMed ID: 19800691 [TBL] [Abstract][Full Text] [Related]
30. Receptor tyrosine kinases as mediators of injury-induced bradykinin B1 receptor expression in rabbit aortic smooth muscle. Koumbadinga GA; Petitclerc E; Bouthillier J; Adam A; Marceau F Eur J Pharmacol; 2009 Mar; 606(1-3):233-9. PubMed ID: 19374866 [TBL] [Abstract][Full Text] [Related]
31. The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors. Bawolak MT; Fortin JP; Vogel LK; Adam A; Marceau F Eur J Pharmacol; 2006 Dec; 551(1-3):108-11. PubMed ID: 17026984 [TBL] [Abstract][Full Text] [Related]
32. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit. Pedersen M; Rönnstrand L; Sun J Cell Signal; 2009 Mar; 21(3):413-8. PubMed ID: 19049823 [TBL] [Abstract][Full Text] [Related]
33. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta -opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. McVey M; Ramsay D; Kellett E; Rees S; Wilson S; Pope AJ; Milligan G J Biol Chem; 2001 Apr; 276(17):14092-9. PubMed ID: 11278447 [TBL] [Abstract][Full Text] [Related]
34. Structural determinants of human proton-coupled folate transporter oligomerization: role of GXXXG motifs and identification of oligomeric interfaces at transmembrane domains 3 and 6. Wilson MR; Kugel S; Huang J; Wilson LJ; Wloszczynski PA; Ye J; Matherly LH; Hou Z Biochem J; 2015 Jul; 469(1):33-44. PubMed ID: 25877470 [TBL] [Abstract][Full Text] [Related]
35. A possible common pharmacophore in the non-peptide antagonists of the bradykinin B1 receptor. Marceau F Trends Pharmacol Sci; 2005 Mar; 26(3):116-8. PubMed ID: 15749155 [No Abstract] [Full Text] [Related]
36. Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. Miura S; Karnik SS; Saku K J Biol Chem; 2005 May; 280(18):18237-44. PubMed ID: 15746093 [TBL] [Abstract][Full Text] [Related]
37. Methods to detect cell surface expression and constitutive activity of GPR6. Prasad BM; Hollins B; Lambert NA Methods Enzymol; 2010; 484():179-95. PubMed ID: 21036233 [TBL] [Abstract][Full Text] [Related]